---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-030876"
form_type: "8-K"
ticker: "NSPR"
cik: "0001433607"
company_name: "InspireMD, Inc."
filed_at: "2022-11-08T23:59:59+00:00"
generated_at: "2026-06-22T03:16:29.233858+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# InspireMD Q3 2022 revenue up 33.6% to $1.43M; net loss widens to $4.5M

## Summary
- CGuard revenue grew 38.8% YoY to $1,430,836; total revenue $1,431,000 (+33.6%).
- Net loss of $4.5M ($0.58/share) vs $4.1M ($0.53) in Q3 2021; operating expenses up 20.7%.
- Cash and equivalents $21.0M at Sep 30, 2022, down from $34.0M at Dec 31, 2021.
- CE Mark under MDR expires Nov 12; company preparing inventory for potential recertification delay.
- C-Guardian US IDE trial on track with 24 sites; enrollment completion expected by end of Q1 2023.

## SEC filing metadata
- accession: 0001493152-22-030876
- form_type: 8-K
- ticker: NSPR
- cik: 0001433607
- company_name: InspireMD, Inc.
- filed_at: 2022-11-08T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1433607/000149315222030876/0001493152-22-030876-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1433607/000149315222030876/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-030876
- JSON: https://secwatch.observer/filing/0001493152-22-030876.json
- Plain text: https://secwatch.observer/filing/0001493152-22-030876.txt

## Key facts
- Earnings Releases
  InspireMD, Inc. reported financial results for three and nine months ended September 30, 2022.
  - Period: three and nine months ended September 30, 2022
  - Result: reported results
  source text: On November 8, 2022, InspireMD, Inc. issued a press release announcing its financial and operating results and recent highlights for the three and nine months ended September 30, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1433607/000149315222030876/0001493152-22-030876-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.